Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

96.250
-1.800-1.84%
Volume:8.90M
Turnover:843.31M
Market Cap:167.96B
PE:204.79
High:96.600
Open:94.200
Low:92.400
Close:98.050
52wk High:112.700
52wk Low:69.550
Shares:1.75B
HK Float Shares:1.75B
Volume Ratio:0.87
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.470
ROE:7.01%
ROA:2.23%
PB:6.92
PE(LYR):204.79
PS:9.14

Loading ...

World's First Cldn18.2 ADC for Regulatory Review: Innovent Biologics Announces Ibi343 (Arcotatug Tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and Nda Accepted by China Nmpa

THOMSON REUTERS
·
Jun 04

BRIEF-Innovent Biologics Says NMPA Accepts NDA For IBI343 (Arcotatug Tavatecan)

Reuters
·
Jun 04

Innovent says China regulator accepts IBI343 gastric cancer NDA for priority review

Reuters
·
Jun 04

Innovent Biologics - Nmpa Accepts Nda for Ibi343 (Arcotatug Tavatecan) for Advanced Gastric Cancer

THOMSON REUTERS
·
Jun 04

Southwest Securities Highlights Innovent Biologics' Strategic Collaboration with Pfizer to Accelerate Oncology Drug Development

Stock News
·
Jun 04

Jiao Yin International Retains 'Buy' Stance on Innovent Bio, Sets Target at HK$105

Stock News
·
Jun 03

Movement Alert|Innovent Biologics Falls 3.04% in Regular Trading, Pfizer Deal Regulatory Uncertainty and Biotech Sector Selloff Weigh on Shares

Market Focus
·
Jun 03

Stock Track | Innovent Biologics Plummets 5.01% Intraday on Pfizer Deal Regulatory Concerns and Biotech Sector Selloff

Stock Track
·
Jun 02

Movement Alert|Innovent Biologics Falls 3.15% in Regular Trading, Pfizer Deal Regulatory Uncertainty Compounds Biotech Sector Selloff

Market Focus
·
Jun 02

Movement Alert|Innovent Biologics Falls 3.12% in Regular Trading, Biotech Sector Pullback Compounds Pfizer Deal Regulatory Uncertainty

Market Focus
·
Jun 01

2026 Asco | Innovent Presents Long-Term Follow-up Results From the Poc Study of Ibi363 (Tak-928) (Pd-1/Il-2Α-Bias Bispecific Fusion Protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Jun 01

Asian Market's May 2026 Stocks Priced Below Estimated Value

Simply Wall St.
·
Jun 01

Hong Kong Market Rises; LENOVO GROUP Surges to New Highs, Property and Biotech Stocks Shine

Stock News
·
May 29

Hong Kong Stocks Rebound on U.S.-Iran Truce Talks; Creality 3D Technology Jumps on Debut

MT Newswires Live
·
May 29

INNOVENT BIO and Pfizer Forge $10.5 Billion Oncology Partnership, Sparking 7% Stock Surge

Deep News
·
May 29

INNOVENT BIO Surges Nearly 9% Following $10.5 Billion Global Partnership Agreement with Pfizer

Stock News
·
May 29

Stock Track | INNOVENT BIO Soars 6.95% Intraday on $10.5 Billion Global Oncology Collaboration with Pfizer

Stock Track
·
May 29

Movement Alert|Innovent Biologics Rises 9.15% in Regular Trading, Signs $10.5 Billion Global Strategic Partnership with Pfizer

Market Focus
·
May 29

Innovent Strikes Up to US$10.5 Billion Global Oncology Pact With Pfizer

TIPRANKS
·
May 29

China and US Agree in Principle to Discuss Reciprocal Tariff Reduction Framework; State Council Issues Urban Renewal 15th Five-Year Plan

Stock News
·
May 29